16
Mar
Enjoying a “liquid facelift” in New Orleans with Sculptra
Dr. Mary Lupo in New Orleans is a board certified dermatologist committed to assisting individuals in rejuvenating their skin and body in cosmetic, medical, and laser dermatology. Her team at the Lupo Center for Aesthetic and General Dermatology believes in providing the best that technology has to offer and provides non-surgical skin rejuvenation techniques that patients can afford.
The most common issue seen by Dr. Mary Lupo in her practice is that of aging. Fine lines, wrinkles, folds, volume loss, and skin laxity are all complaints brought forward by new and existing patients who visit the Lupo Center for Aesthetic and General Dermatology. While a surgical facelift is always an option, it is best suited for patients with severe instances of skin laxity and volume loss. Patients with mild to moderate concerns are often not good candidates for treatment and they are looking for more affordable, less invasive ways of addressing these problems. Thanks to continued advances in dermatology, patients can now use Sculptra injections to enjoy a “liquid facelift” along with other injectables such as neuromodulators and dermal fillers.
Sculptra stands apart from other injectables because it is made of Poly-L-Lactic Acid and helps in stimulating the production of new collagen. Collagen is what gives the skin volume and youthfulness. As we age, we begin to lose collagen in the skin and notice relaxation, which causes volume loss and imperfections such as fine lines and wrinkles. Sculptra can help reverse some of these concerns and bring back a more youthful appearance.
Sculptra does not show immediate results in the same way dermal fillers do, but the gradual improvement is often more natural in appearance. Neuromodulators such as Botox and Dysport, are also available through the Lupo Center for Aesthetic and General Dermatology, but are better used on areas such as the upper portion of the face instead of specific fine lines and wrinkles on the rest of the face. Dr. Mary Lupo suggests a consultation appointment for patients to determine the best injectables for them—and decide if a combination of injectables is best for optimum results.
Lupo Center for Aesthetic and General Dermatology
Mary P. Lupo, M.D. – Connect on Instagram
Our mission at the Lupo Center is to provide patients with innovative, effective, and ethical care to make each person look and feel their personal best. To fulfill our goal, we provide state-of-the-art medical, surgical, and cosmetic treatments to all patients.
Board-certified dermatologist and clinical professor of dermatology Mary P. Lupo, MD, has been a leader in the field of non-surgical rejuvenation since 1983. She travels internationally to teach her innovative techniques, and her reputation brings in patients from around the country. She started the first formal residency training program for injectables and peels in 1983 at Tulane Medical School and served as past president of the Women’s Dermatologic Society, adjunct professor of dermatology at Tulane, and a founder of Cosmetic Boot Camp. Dr. Lupo holds membership in many prestigious dermatology associations, participates in clinical trials for the approval of new drugs and devices, and acts as an advisor for numerous aesthetic-minded companies.
Dr. Lupo was recently recognized as a trailblazer for women in dermatology and for her dedication to educating dermatology residents and fellows.
She has also received the following awards:
- 𝐋𝐢𝐟𝐞𝐭𝐢𝐦𝐞 𝐂𝐚𝐫𝐞𝐞𝐫 𝐄𝐝𝐮𝐜𝐚𝐭𝐨𝐫 𝐀𝐰𝐚𝐫𝐝 from the 𝐃𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧 – Recognizes full-time academicians who have dedicated their careers to educating dermatology residents and fellows;
- 𝐖𝐢𝐥𝐦𝐚 𝐁𝐞𝐫𝐠𝐟𝐞𝐥𝐝, 𝐌𝐃 𝐕𝐢𝐬𝐢𝐨𝐧𝐚𝐫𝐲 and 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐀𝐰𝐚𝐫𝐝 from the 𝐖𝐨𝐦𝐞𝐧’𝐬 𝐃𝐞𝐫𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐢𝐜 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 – Recognizes dermatologists of national prominence who have been trailblazers for women in some aspect of dermatology.
Dr. Lupo has authored over 90 published articles and book chapters and has spoken on various dermatological topics at nearly 480 national and international meetings and seminars.